Cadence Neuroscience
Jay Tzucker has a diverse work experience in the software engineering field spanning over 40 years.
Jay is currently a Senior Software Engineer at Cadence Neuroscience Inc. since December 2022.
Prior to this, they worked as a UX/UI Software Manager at TechMah Medical LLC from June 2022 to December 2022.
From July 2017 to June 2022, Jay held the position of Principal Embedded Software Engineer (GUI) at Physio-Control, now part of Stryker.
Before that, they worked as a Senior Software Engineer at RareCyte, Inc. from September 2010 to July 2017.
Jay also has experience working at Boston Scientific as a Principal Software Engineer from 2000 to 2010, and as a Senior Software Engineer from 1998 to 2000.
Jay previously held the role of Senior Software Engineer at InControl, Inc. from 1996 to 1998.
Jay's work experience also includes roles as a Software Engineer III at Spacelabs Healthcare from 1990 to 1996,
a Senior Software Engineer at Biosound, Inc. from 1988 to 1990, and a Software Systems Engineer at Von Duprin, Inc. (Div. Ingersoll Rand Corp.) in 1988.
Jay started their career as a Sr. Software Engineer at Genus from 1983 to 1987.
Jay Tzucker earned a Bachelor of Science (BS) degree in Electrical Engineering with a specialization in Digital Systems from Purdue University, which they attended from 1976 to 1979. Later, in 2008, they completed a Certificate Program in Java Programming at the University of Washington Extension. In 2009, they pursued a Certificate Program in Perl Programming at the same institution. In 2010, they further enhanced their skills by completing a Certificate Program in C++ Programming at the University of Washington Extension. Lastly, in 2014, Jay Tzucker obtained a Certificate Program in Web Technology Solutions from the University of Washington Extension.
This person is not in any teams
Cadence Neuroscience
Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with a procedure thatcan be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.